You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
亞虹醫藥(688176.SH):全球膀胱癌新發患者人數預計至2025年增長到65.1萬人
格隆匯 04-28 15:32

格隆匯4月28日丨有投資者向亞虹醫藥(688176.SH)提問:NMIBC患者數量大概有多少?

亞虹醫藥回覆:根據弗若斯特沙利文分析,全球膀胱癌新發患者人數由2016年的52.0萬人增長到2020年的57.3萬人,預計至2025年增長到65.1萬人,至2030年達到73.6萬人;中國膀胱癌新發患者人數由2016年的7.7萬人增長到2020年的8.6萬人,預計至2025年增長到10.1萬人,至2030年達到11.8萬人。由於NMIBC患者生存週期較長,存量患者人數遠大於每年新發患者人數。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account